Join
Live feed
·
NEWSReleasevia Quantisnow
Acer Therapeutics Inc. logo

Bayer's Third Menopausal Relief Drug Trial Meets Primary Goal, German Conglomerate Seeks FDA Approval For Elinzanetant

ByQuantisnow·Wall Street's wire, on your screen.
ACER· Acer Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ACER (Acer Therapeutics Inc.) and more on Quantisnow.